rs118102196

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_006087.4(TUBB4A):​c.921C>T​(p.His307His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0205 in 1,613,948 control chromosomes in the GnomAD database, including 429 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 24 hom., cov: 32)
Exomes 𝑓: 0.021 ( 405 hom. )

Consequence

TUBB4A
NM_006087.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.938
Variant links:
Genes affected
TUBB4A (HGNC:20774): (tubulin beta 4A class IVa) This gene encodes a member of the beta tubulin family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. Mutations in this gene cause hypomyelinating leukodystrophy-6 and autosomal dominant torsion dystonia-4. Alternate splicing results in multiple transcript variants encoding different isoforms. A pseudogene of this gene is found on chromosome X. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 19-6495578-G-A is Benign according to our data. Variant chr19-6495578-G-A is described in ClinVar as [Benign]. Clinvar id is 240288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-6495578-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.938 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0149 (2272/152338) while in subpopulation NFE AF = 0.0239 (1623/68020). AF 95% confidence interval is 0.0229. There are 24 homozygotes in GnomAd4. There are 998 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2272 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBB4ANM_006087.4 linkc.921C>T p.His307His synonymous_variant Exon 4 of 4 ENST00000264071.7 NP_006078.2 P04350

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBB4AENST00000264071.7 linkc.921C>T p.His307His synonymous_variant Exon 4 of 4 1 NM_006087.4 ENSP00000264071.1 P04350

Frequencies

GnomAD3 genomes
AF:
0.0150
AC:
2276
AN:
152220
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00429
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0123
Gnomad ASJ
AF:
0.0305
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00620
Gnomad FIN
AF:
0.00659
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0239
Gnomad OTH
AF:
0.0211
GnomAD2 exomes
AF:
0.0164
AC:
4102
AN:
250082
AF XY:
0.0167
show subpopulations
Gnomad AFR exome
AF:
0.00331
Gnomad AMR exome
AF:
0.0118
Gnomad ASJ exome
AF:
0.0289
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00634
Gnomad NFE exome
AF:
0.0250
Gnomad OTH exome
AF:
0.0208
GnomAD4 exome
AF:
0.0211
AC:
30774
AN:
1461610
Hom.:
405
Cov.:
32
AF XY:
0.0207
AC XY:
15069
AN XY:
727140
show subpopulations
African (AFR)
AF:
0.00353
AC:
118
AN:
33474
American (AMR)
AF:
0.0119
AC:
531
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
752
AN:
26104
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.00864
AC:
745
AN:
86236
European-Finnish (FIN)
AF:
0.00828
AC:
442
AN:
53362
Middle Eastern (MID)
AF:
0.0381
AC:
219
AN:
5754
European-Non Finnish (NFE)
AF:
0.0240
AC:
26722
AN:
1111896
Other (OTH)
AF:
0.0206
AC:
1242
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
2723
5446
8170
10893
13616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
976
1952
2928
3904
4880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0149
AC:
2272
AN:
152338
Hom.:
24
Cov.:
32
AF XY:
0.0134
AC XY:
998
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00428
AC:
178
AN:
41584
American (AMR)
AF:
0.0123
AC:
188
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0305
AC:
106
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00600
AC:
29
AN:
4834
European-Finnish (FIN)
AF:
0.00659
AC:
70
AN:
10626
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0239
AC:
1623
AN:
68020
Other (OTH)
AF:
0.0208
AC:
44
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
131
261
392
522
653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0219
Hom.:
13
Bravo
AF:
0.0150
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.0256
EpiControl
AF:
0.0289

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypomyelinating leukodystrophy 6 Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
May 20, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Torsion dystonia 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

TUBB4A-related disorder Benign:1
Jan 30, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
9.4
DANN
Benign
0.60
PhyloP100
0.94
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118102196; hg19: chr19-6495589; API